Palivizumab Use in Very Premature Infants in the Neonatal Intensive Care Unit

The purpose of this study was to determine the ability of young hospitalized premature (born < or =30 weeks' gestational age) infants to achieve serum levels of palivizumab that are protective against RSV infection. Palivizumab, 15 mg/kg per dose intramuscularly, was administered every 28 da...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatrics (Evanston) 2004-11, Vol.114 (5), p.e554-e556
Hauptverfasser:	Wu, Shou-Yien, Bonaparte, Joel, Pyati, Suma
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - blood Antibodies, Monoclonal, Humanized Antiviral Agents - administration & dosage Antiviral Agents - blood Dose-Response Relationship, Drug Female Gestational Age Humans Infant, Newborn Infant, Premature - blood Infant, Premature, Diseases - prevention & control Injections, Intramuscular Intensive Care Units, Neonatal Male Palivizumab Prospective Studies Respiratory Syncytial Virus Infections - prevention & control Respiratory Syncytial Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!